ARTICLE | Company News
Oxford BioMedica, King's College deal
February 12, 2001 8:00 AM UTC
OXB exclusively licensed retinoic acid receptor (RAR) beta 2, a gene associated with nerve regeneration, from the college. OXB said it will combine its LentiVector gene delivery technology with the g...